Latest Breaking News On - Stevenb binder - Page 1 : comparemela.com

MannKind Announces CFO Transition

MannKind Announces CFO Transition
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Stevenb binderMannkind corporationExecutive vice presidentSpecial projects

MannKind Announces CFO Transition

MannKind Announces CFO Transition
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Loyola marymount universityUnited statesWestlake villageChristopher prentissMichael castagnaStevenb binderSteve binderIntermune incSupernus pharmaceuticals incExchange commissionIndiana university kelley school of businessAdamas pharmaceuticals incMannkind corporation nasdaqMannkind corporationDynavax technologies corporationAdarx pharmaceuticals inc

MannKind Announces CFO Transition

Steven B. Binder announces planned retirement and is appointed Executive Vice President, Special Projects, effective April 22, 2024, through Decem.

Loyola marymount universityUnited statesWestlake villageSteve binderChristopher prentissStevenb binderMichael castagnaAdamas pharmaceuticals incIntermune incAdarx pharmaceuticals incMannkind corporationDynavax technologies corporationIndiana university kelley school of businessSupernus pharmaceuticals incExchange commissionMannkind corporation nasdaq

MannKind (NASDAQ:MNKD) PT Raised to $7 50

MannKind (NASDAQ:MNKD) PT Raised to $7 50
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Michael castagnaStevenb binderAlfrede mannInternational assets investment managementUs bancorpMannkind corpRaymond james financial services advisors incHightower advisorsMannkind company profileSecurities exchange commissionCantor fitzgeraldRaymond james associatesGet free reportKind trading downExchange commissionAssets investment management

MannKind (NASDAQ:MNKD) PT Raised to $7 50

MannKind (NASDAQ:MNKD – Get Free Report) had its price target upped by investment analysts at Cantor Fitzgerald from $6.50 to $7.50 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has an “overweight” rating on the biopharmaceutical company’s stock. Cantor Fitzgerald’s target price indicates a potential upside of 41.78% from […]

Michael castagnaAlfrede mannStevenb binderCantor fitzgeraldSecurities exchange commissionCetera advisor networksTopco ltdMannkind company profileFirst horizon advisors incMannkind corpCetera advisorsInternational assets investment managementGet free reportKind stock downExchange commissionAssets investment management